RecruitingNCT06419699

CPAx: Responsiveness and Minimal Clinically Important Difference

Studying Paraneoplastic neurologic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Insel Gruppe AG, University Hospital Bern
Principal Investigator
Sabrina Eggmann, PhD
Inselspital, Bern University Hospital, Switzerland; Monash University, Australia
Enrollment
120 target
Eligibility
18 years · All sexes
Timeline
20242025

Study locations (3)

Collaborators

Monash University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06419699 on ClinicalTrials.gov

Other trials for Paraneoplastic neurologic syndrome

Additional recruiting or active studies for the same condition.

See all trials for Paraneoplastic neurologic syndrome

← Back to all trials